REMODULIN Side Effects

7020437-4 |
on Sep 17, 2010 Female patient from CANADA , 29 years of age, was treated with Remodulin (View Usage). . Remodulin dosage: 180 Ug/kg (0.125 Ug/kg, 1 In 1 Min), Subcutaneous.

7020268-5 |
Patient was taking Remodulin (View Usage). on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 29 years of age, . Remodulin dosage: Intravenous.

7020267-3 |
Adverse event was reported on Sep 21, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: Intravenous) . Location: UNITED STATES , weighting 98.11 lb, .

7020170-9 | Convulsion, Subdural Haematoma
on Sep 15, 2010 Female patient from UNITED STATES , 40 years of age, weighting 137.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, subdural haematoma. Remodulin dosage: 165.6 Ug/kg (0.115 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with ORAL CONTRACEPTIVES (ORAL CONTRACEPTIVE NOS) (View Oral Contraceptives (oral Contraceptive Nos) Review and Oral Contraceptives (oral Contraceptive Nos) Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.


7020140-0 | Abdominal Pain, Atrial Fibrillation, Chest Pain, Haematemesis, Mitral Valve Incompetence, Sinus Tachycardia, Stress Cardiomyopathy, Supraventricular Extrasystoles, Troponin Increased
on Sep 12, 2010 Female patient from UNITED STATES , 69 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Remodulin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), atrial fibrillation (What is atrial fibrillation?), chest pain (What is chest pain?), haematemesis, mitral valve incompetence, sinus tachycardia, stress cardiomyopathy, supraventricular extrasystoles, troponin increased. Remodulin dosage: Subcutaneous. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

7020137-0 | Anuria, Breast Discolouration, Clostridial Infection, Skin Discolouration, Weight Decreased
Patient was taking Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: anuria, breast discolouration, clostridial infection, skin discolouration, weight decreased on Sep 17, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, . Remodulin dosage: Subcutaneous. Patient was hospitalized.

7020119-9 | Haemoptysis, Thrombosis In Device
Adverse event was reported on Sep 20, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 216 Ug/kg (0.15 Ug/kg, 1 In 1 Min), Subcutaneous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 54 years of age, weighting 160.7 lb, Patient experienced the following unwanted or unexpected effects: haemoptysis, thrombosis in device. During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ), LETAIRIS (AMBRISENTAN) (View Letairis (ambrisentan) Review and Letairis (ambrisentan) Label ), ADCIRCA (TADALAFIL) (View Adcirca (tadalafil) Review and Adcirca (tadalafil) Label ). Patient was hospitalized.

7014753-X | Asthenia, Disorientation, Dysarthria, Fall, Haematoma, Head Injury, Somnolence, Upper Limb Fracture
on Sep 10, 2010 Female patient from UNITED STATES , 65 years of age, was treated with Remodulin (View Usage). Patient had the following side effects: asthenia, disorientation, dysarthria, fall (What is fall?), haematoma, head injury, somnolence, upper limb fracture. Remodulin dosage: 129.6 Ug/kg (0.09 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LYRICA (View Lyrica Review and Lyrica Label ), K DUR (POTASSIUM) (View K-dur (potassium) Review and K-dur (potassium) Label ), LANTUS (View Lantus Review and Lantus Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METOLAZONE (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

7014681-X | Anaemia
on Sep 11, 2010 Female patient from UNITED STATES , 37 years of age, weighting 204.4 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: anaemia. Remodulin dosage: 14.4 Ug/kg (0.01 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LANTUS (View Lantus Review and Lantus Label ), CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

7012724-0 | Hepatic Neoplasm Malignant
Patient was taking Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with pulmonary arterial hypertension and. Remodulin dosage: 36 Ug/kg (0.025 Ug/kg,1 In 1 Min),subcutaneous. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PREMPRO (PROVELLA 14) (View Prempro (provella-14) Review and Prempro (provella-14) Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

7012721-5 | Anaemia, Influenza Like Illness
Adverse event was reported on Sep 09, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 191.52 Ug/kg (0.133 Ug/kg,1 In 1 Min),subcutaneous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 57 years of age, weighting 224.0 lb, Patient had the following side effects: anaemia, influenza like illness. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LYRICA (View Lyrica Review and Lyrica Label ), ALLEGRA (View Allegra Review and Allegra Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

7012706-9 | Infusion Site Abscess
on Sep 09, 2010 Female patient from UNITED STATES , 33 years of age, weighting 110.2 lb, was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: infusion site abscess. Remodulin dosage: 46.08 Ug/kg (0.032 Ug/kg,l In 1 Min),subcutaneous. During the same period patient was treated with LETAIRIS (AMBRISENTAN) (View Letairis (ambrisentan) Review and Letairis (ambrisentan) Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

7012697-0 | Pneumonia
on Sep 08, 2010 Female patient from UNITED STATES , 55 years of age, weighting 172.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Remodulin dosage: 129.6 Ug/kg (0.09 Ug/kg, 1 In 1 Min),intravenous. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NEXIUM (View Nexium Review and Nexium Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

7012693-3 | Hyperthyroidism
Patient was taking Remodulin (View Usage). Patient had the following side effects: hyperthyroidism on Sep 14, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 149.9 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Remodulin dosage: 345.6 Ug/kg (0.24 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with IMODIUM (View Imodium Review and Imodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), AMSIEN (ZOLPIDEM TARTRATE) (View Amsien (zolpidem Tartrate) Review and Amsien (zolpidem Tartrate) Label ), REVATIO (View Revatio Review and Revatio Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

7012680-5 | Infusion Site Pustule, Purulence
Adverse event was reported on Sep 10, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 100.8 Ug/kg (0.07 Ug/kg, 1 In 1 Min), Subcutaneous) . Location: UNITED STATES , 35 years of age, weighting 214.3 lb, After Remodulin was administered, patient had the following side effects: infusion site pustule, purulence. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), MORPHINE (View Morphine Review and Morphine Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6995218-8 | Epistaxis
on Sep 09, 2010 Female patient from UNITED STATES , weighting 160.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis. Remodulin dosage: 75.6 Ug/kg (0.0525 Ug/kg, 1 In 1 Min) Subcutaneous. During the same period patient was treated with WARFARIN SODIUM (1.5 Mg (1.5 Mg, 1 In 1 D)) (View Warfarin Sodium Review and Warfarin Sodium Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), LASIX (View Lasix Review and Lasix Label ), LETAIRIS (AMBRISENTAN) (View Letairis (ambrisentan) Review and Letairis (ambrisentan) Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

6995216-4 | Convulsion, Subdural Haematoma
on Sep 03, 2010 Female patient from UNITED STATES , 40 years of age, weighting 137.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient had the following side effects: convulsion, subdural haematoma. Remodulin dosage: 165.6 Ug/kg (0.115 Ug/kg, 1 In 1 Min) Intravenous. During the same period patient was treated with ORAL CONTRACEPTIVES (ORAL CONTRACEPTIVE NOS) (View Oral Contraceptives (oral Contraceptive Nos) Review and Oral Contraceptives (oral Contraceptive Nos) Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6995215-2 |
Patient was taking Remodulin (View Usage). on Sep 03, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 208.3 lb, was diagnosed with pulmonary arterial hypertension and. Remodulin dosage: 76.32 Ug/kg (0.053 Ug/kg, 1 In 1 Min) Subcutaneous. During the same period patient was treated with CIALIS (View Cialis Review and Cialis Label ), AMBIEN (View Ambien Review and Ambien Label ), LASIX (View Lasix Review and Lasix Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ).

6995192-4 |
Adverse event was reported on Sep 02, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 0.153 Ug/kg (0.153 Ug/kg, 1 In 1 D) Intravenous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 74 years of age, .

6995188-2 |
on Sep 02, 2010 Female patient from UNITED STATES , 64 years of age, weighting 96.12 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). . Remodulin dosage: 76.32 Ug/kg (0.053 Ug/kg, 1 In 1 Min) ,intravenous. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ), GAS X (SIMETICONE) (View Gas X (simeticone) Review and Gas X (simeticone) Label ).

6994995-X | Angiopathy, Gastric Disorder, Gastric Ulcer, Haematemesis, Haematochezia, Thrombosis
on Aug 31, 2010 Female patient from UNITED STATES , 59 years of age, was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: angiopathy, gastric disorder, gastric ulcer, haematemesis, haematochezia, thrombosis. Remodulin dosage: Subcutaneous. Patient was hospitalized.

6994994-8 | Abdominal Pain, Pulmonary Arterial Hypertension
Patient was taking Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), pulmonary arterial hypertension on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 108.9 lb, was diagnosed with pulmonary arterial hypertension and. Remodulin dosage: 72 Ug/kg (0.05 Ug/kg, 1 In 1 Min), Ntravenous. During the same period patient was treated with GAS X (SILICON DIOXIDE W/SIMETICONE) (View Gas-x (silicon Dioxide W/simeticone) Review and Gas-x (silicon Dioxide W/simeticone) Label ), LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), PREVACID (View Prevacid Review and Prevacid Label ), PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ). Patient was hospitalized.

6970144-9 | Hyperthyroidism
Adverse event was reported on Aug 27, 2010 by a Male patient taking Remodulin (View Usage) (Dosage: 345.6 Ug/kg (0.24 Ug/kg, 1 In 1 Min), Intravenous) . Location: UNITED STATES , 49 years of age, weighting 149.9 lb, Patient had the following side effects: hyperthyroidism. During the same period patient was treated with IMODIUM (View Imodium Review and Imodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), AMBIEN (View Ambien Review and Ambien Label ), REVATIO (View Revatio Review and Revatio Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6970132-2 | Abdominal Pain
on Aug 24, 2010 Female patient from UNITED STATES , 64 years of age, weighting 108.9 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?). Remodulin dosage: 72 Ug/kg (0.05 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with GAS X (SILICON DIOXIDE W/SIMETICONE) (View Gas-x (silicon Dioxide W/simeticone) Review and Gas-x (silicon Dioxide W/simeticone) Label ), LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), PREVACID (View Prevacid Review and Prevacid Label ), PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ). Patient was hospitalized.

6970126-7 | Urinary Tract Infection
on Aug 23, 2010 Female patient from UNITED STATES , 64 years of age, was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: urinary tract infection (What is urinary tract infection?). Remodulin dosage: 115.2 Ug/kg (0.08 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

6969591-0 | Device Related Infection, Fall, Pneumonia
Patient was taking Remodulin (View Usage). Patient had the following side effects: device related infection, fall (What is fall?), pneumonia (What is pneumonia?) on Aug 26, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 218.0 lb, was diagnosed with pulmonary arterial hypertension and. Remodulin dosage: 80.64 Ug/kg (0.056 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with LETAIRIS (AMBRISENTAN) (View Letairis (ambrisentan) Review and Letairis (ambrisentan) Label ), LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ), REVATIO (View Revatio Review and Revatio Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6956937-2 | Dyspnoea
Adverse event was reported on Aug 20, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 158.4 Ug/kg (0.11 Ug/kg, 1 In 1 Min), Intravenous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 36 years of age, weighting 151.0 lb, After Remodulin was administered, patient had the following side effects: dyspnoea. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), TRACLEER (View Tracleer Review and Tracleer Label ), NASONEX (View Nasonex Review and Nasonex Label ), BUMEX (View Bumex Review and Bumex Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), IMODIUM A D (View Imodium A-d Review and Imodium A-d Label ), EXTRA STRENGTH TYLENOL (View Extra Strength Tylenol Review and Extra Strength Tylenol Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6956933-5 | Pulmonary Arterial Hypertension, Respiratory Failure, Sepsis
on Aug 19, 2010 Female patient from UNITED STATES , weighting 130.3 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary arterial hypertension, respiratory failure, sepsis (What is sepsis?). Remodulin dosage: 50.4 Ug/kg (0.035 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), REVATIO (View Revatio Review and Revatio Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), METOLAZONE (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

6956932-3 | Disease Progression, Erythema, Infusion Site Haemorrhage, Infusion Site Infection, Mental Disorder, Oedema, Pain, Pulmonary Hypertension, Scar
on Aug 17, 2010 Female patient from UNITED STATES , 67 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Remodulin (View Usage). Patient had the following side effects: disease progression, erythema, infusion site haemorrhage, infusion site infection, mental disorder, oedema, pain (What is pain?), pulmonary hypertension (What is pulmonary hypertension?), scar (What is scar?). Remodulin dosage: Subcutaneous. Patient was hospitalized.

6936111-6 | Asthenia, Fatigue, Gastrointestinal Haemorrhage, Heart Rate Irregular, Hypersomnia, Malaise, Presyncope
Patient was taking Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: asthenia, fatigue, gastrointestinal haemorrhage, heart rate irregular, hypersomnia, malaise, presyncope on Aug 03, 2010 from CANADA Additional patient health information: Female patient , 18 years of age, . Remodulin dosage: Pump Rate .016. Patient was hospitalized.

6932521-1 | Respiratory Disorder
Adverse event was reported on Aug 11, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 50.4 Ug/kg (0.035 Ug/kg, 1 In 1 Min), Intravenous) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , weighting 130.3 lb, Patient experienced the following unwanted or unexpected effects: respiratory disorder. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), REVATIO (View Revatio Review and Revatio Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), METOLAZONE (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

6932520-X | Inflammation, Liver Disorder
on Aug 06, 2010 Female patient from UNITED STATES , 55 years of age, weighting 130.1 lb, was treated with Remodulin (View Usage). Patient had the following side effects: inflammation, liver disorder. Remodulin dosage: 77.472 Ug/kg (0.0538 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), NEXIUM (View Nexium Review and Nexium Label ), METANX (METANX) (View Metanx (metanx) Review and Metanx (metanx) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), URSO FORTE (View Urso Forte Review and Urso Forte Label ), EVOXAC (View Evoxac Review and Evoxac Label ). Patient was hospitalized.

6932519-3 | Asthenia, Confusional State, Dialysis, Diarrhoea
on Aug 04, 2010 Male patient from UNITED STATES , 42 years of age, was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: asthenia, confusional state, dialysis (What is dialysis?), diarrhoea. Remodulin dosage: 72 Ug/kg (0.05 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6932516-8 | Oedema, Pneumonia
Patient was taking Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: oedema, pneumonia (What is pneumonia?) on Aug 04, 2010 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 205.0 lb, . Remodulin dosage: 67.68 Ug/kg (0.047 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), PAXIL (View Paxil Review and Paxil Label ), LASIX (View Lasix Review and Lasix Label ), TYLENOL #3 (SOLPADEINE /00154101/) (View Tylenol #3 (solpadeine /00154101/) Review and Tylenol #3 (solpadeine /00154101/) Label ), COUMADIN (View Coumadin Review and Coumadin Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), KLOR CON (View Klor-con Review and Klor-con Label ). Patient was hospitalized.

6932503-X | Dizziness, Headache, Pyrexia
Adverse event was reported on Aug 04, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 35.4528 Ug/kg (0.02462 Ug/kg, 1 In 1 Min), Intravenous) . Location: UNITED STATES , child 9 years of age, weighting 59.08 lb, Patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), pyrexia. During the same period patient was treated with MEPHYTON (PHYTOMENADIONE) (View Mephyton (phytomenadione) Review and Mephyton (phytomenadione) Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), REVATIO (View Revatio Review and Revatio Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

6932501-6 | Pneumonia
on Aug 03, 2010 Female patient from UNITED STATES , 75 years of age, weighting 90.39 lb, was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: pneumonia (What is pneumonia?). Remodulin dosage: 80.64 Ug/kg (0.056 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with DETROL LA (View Detrol La Review and Detrol La Label ), CELEBREX (View Celebrex Review and Celebrex Label ), FLUTICASONE (FLUTICASONE) (SPRAY (NOT INHALATION)) (View Fluticasone (fluticasone) (spray (not Inhalation)) Review and Fluticasone (fluticasone) (spray (not Inhalation)) Label ), NORVASC (View Norvasc Review and Norvasc Label ), REVATIO (View Revatio Review and Revatio Label ), FIBERTAB (FIBRE, DIETARY) (View Fibertab (fibre, Dietary) Review and Fibertab (fibre, Dietary) Label ), PLAVIX (View Plavix Review and Plavix Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6932462-X | Cardiomegaly, Chest Pain, Condition Aggravated, Dyspnoea, Fibrin D Dimer Increased, Lymphadenopathy, Pleural Effusion, Productive Cough
on Aug 05, 2010 Female patient from UNITED STATES , weighting 173.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomegaly, chest pain (What is chest pain?), condition aggravated, dyspnoea, fibrin d dimer increased, lymphadenopathy, pleural effusion, productive cough. Remodulin dosage: 55.8 Ug/kg (0.03875 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

6917360-X | Cardiac Failure Congestive, Conjunctivitis, Fatigue, Pneumonia Bacterial, Pulmonary Thrombosis
Patient was taking Remodulin (View Usage). Patient had the following side effects: cardiac failure congestive, conjunctivitis, fatigue, pneumonia bacterial, pulmonary thrombosis on Jul 29, 2010 from UNITED STATES Additional patient health information: Female patient , 27 years of age, weighting 250.0 lb, . Remodulin dosage: Subcutaneous. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6907245-7 |
Adverse event was reported on Jul 21, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: Subcutaneous) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: ITALY , 63 years of age, .

6905318-6 | Convulsion
on Jul 19, 2010 Female patient from UNITED STATES , child 6 years of age, weighting 39.02 lb, was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Remodulin dosage: 52.848 Ug/kg (0.0367 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), REVATIO (View Revatio Review and Revatio Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), MIRALAX (View Miralax Review and Miralax Label ), TRACLEER (View Tracleer Review and Tracleer Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

6905317-4 | Deep Vein Thrombosis
on Jul 19, 2010 Female patient from UNITED STATES , 51 years of age, weighting 239.4 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Remodulin dosage: 80.64 Ug/kg (0.056 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with DARVOCET (View Darvocet Review and Darvocet Label ), LASIX (View Lasix Review and Lasix Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NORVASC (View Norvasc Review and Norvasc Label ), REVATIO (View Revatio Review and Revatio Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

6905299-5 | Fluid Retention
Patient was taking Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: fluid retention on Jul 20, 2010 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 264.6 lb, . Remodulin dosage: 106.56 Ug/kg (0.074 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), INSPRA (View Inspra Review and Inspra Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MAG OXIDE (MAGNESIUM OXIDE) (View Mag Oxide (magnesium Oxide) Review and Mag Oxide (magnesium Oxide) Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6905298-3 | Blood Potassium Decreased, Hypotension, Infusion Site Infection
Adverse event was reported on Jul 22, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 34.56 Ug/kg (0.024 Ug/kg, 1 In 1 Min), Subcutaneous) . Location: UNITED STATES , 46 years of age, weighting 76.06 lb, Patient experienced the following unwanted or unexpected effects: blood potassium decreased, hypotension, infusion site infection. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PREVACID (View Prevacid Review and Prevacid Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6905294-6 | Pulmonary Oedema
on Jul 22, 2010 Female patient from UNITED STATES , 55 years of age, weighting 233.7 lb, was treated with Remodulin (View Usage). Patient had the following side effects: pulmonary oedema. Remodulin dosage: 67.68 Ug/kg (0.047 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LETAIRIS (AMBRISENTAN) (View Letairis (ambrisentan) Review and Letairis (ambrisentan) Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), KLOR CON (View Klor-con Review and Klor-con Label ), EVISTA (View Evista Review and Evista Label ). Patient was hospitalized.

6895843-9 | Lymphadenopathy
on Jul 20, 2010 Female patient from UNITED STATES , 42 years of age, weighting 169.8 lb, was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: lymphadenopathy. Remodulin dosage: 37.44 Ug/kg (0.026 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), TASIGNA (NILOTINIB HYDROCHLORIDE) (View Tasigna (nilotinib Hydrochloride) Review and Tasigna (nilotinib Hydrochloride) Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6895813-0 | Fluid Retention
Patient was taking Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: fluid retention on Jul 15, 2010 from UNITED STATES Additional patient health information: Female patient , 45 years of age, . Remodulin dosage: 123.84 Ug/kg (0.086 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CELEXA (View Celexa Review and Celexa Label ). Patient was hospitalized.

6895811-7 | Pulmonary Thrombosis
Adverse event was reported on Jul 15, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 55.8 Ug/kg (0.03875 Ug/kg, 1 In 1 Min), Intravenous) . Location: UNITED STATES , 44 years of age, weighting 173.1 lb, Patient had the following side effects: pulmonary thrombosis. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), LASIX (View Lasix Review and Lasix Label ), REVATIO (View Revatio Review and Revatio Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

6862967-1 |
on Jul 08, 2010 Female patient from ITALY , 63 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Remodulin (View Usage). . Remodulin dosage: Subcutaneous.

6862204-8 | Pneumonia
on Jul 07, 2010 Female patient from UNITED STATES , 42 years of age, was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Remodulin dosage: 83.52 Ug/kg (0.058 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6862196-1 | Dehydration
Patient was taking Remodulin (View Usage). Patient had the following side effects: dehydration on Jul 06, 2010 from UNITED STATES Additional patient health information: Female patient , 70 years of age, weighting 157.4 lb, . Remodulin dosage: 82.08 Ug/kg (0.057 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with CENTRUM SILVER (CENTRUM SILVER /01292501/) (View Centrum Silver (centrum Silver /01292501/) Review and Centrum Silver (centrum Silver /01292501/) Label ), SINGULARI (MONTELUKAST) (View Singulari (montelukast) Review and Singulari (montelukast) Label ), JANUVIA (View Januvia Review and Januvia Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), REVATIO (View Revatio Review and Revatio Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ). Patient was hospitalized.